Cases 61 - 70 of 361
QUARLES v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv03385
Plaintiff:
WILLIE QUARLES
Defendant:
AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. HETERO LABS LIMITED UNIT V et al
as 2:2022cv03212
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant:
HETERO LABS LIMITED UNIT V and HETERO USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
THE ESTATE OF CONNIE KEEP v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02461
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CHARLES KEEP and THE ESTATE OF CONNIE KEEP
Defendant:
AUROBINDO PHARMA, LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS PHARMA INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
PARKER v. HETERO DRUGS, LTD. et al
as 1:2022cv02419
Plaintiff:
ROBERT GLENN PARKER
Defendant:
HETERO DRUGS, LTD., HETERO LABS, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
EISAI CO., LTD. et al v. HETERO USA INC. et al
as 1:2022cv01795
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
HETERO USA INC., HETERO LABS LIMITED and HETERO LABS LIMITED UNIT-III
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. et al v. Hetero Labs Limited et al
as 1:2022cv00378
Plaintiff:
Merck Sharp & Dohme Corp., MSD International Business GmbH, MSD International GmbH and others
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MATHIS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01246
Plaintiff:
BENNY MATHIS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
POMA v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01118
Defendant:
FRANCESCO POMA, ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GRUBB et al v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00918
Plaintiff:
ESTATE OF DUDLEY WAYNE GRUBB and TERESA A. GRUBB
Defendant:
AUROBINDO PHARMA, LTD., ARROW PHARMA (MALTA) LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
